ANN ARBOR — The Ann Arbor life sciences products and services provider Essen BioScience Inc. has named Brett Williams as its new president and CEO.
Williams succeeds Kirk Schroeder, who will stay with the business as vice president of research and development. Schroeder co-founded the company with Brad Neagle, who has the title vice president of engineering and operations.
Essen provides analytical instrumentation, software, reagents and
services used in cell-based life science research.
Williams comes to Essen from Thermo Fisher Scientific (formerly
Life Technologies), where he served in a number of capacities,
including, most recently, vice president and general manager of the
cellular analysis business unit. Previously, he was cellular analysis
market development leader and senior director of cellular analysis
Schroeder said Williams “has the right experience, approach and
energy to lead our company forward and his addition will allow Brad
and me to focus exclusively on continued product innovation. I’m
confident that the combination of Brett’s leadership, our record of
innovation and the strategic and financial resources of SFW Capital is a formula for continued, long term success.”
Said Williams: “The team at Essen has a long history of developing
ground-breaking instruments that have proven to be major enablers in the cell-based research market. Essen has unique and differentiated product technology with a broad set of very high-value applications, deep customer relationships and an extremely innovative culture. It was a very compelling opportunity for me to lead the team at Essen and build upon the Company’s strong foundation, and partner with Kirk, Brad and the rest of the management team to make the investments that will insure that we can continue to deliver innovative solutions and excellent service to our customers.”
Essen’s flagship product, the IncuCyte Zoom live-content imaging
system, provides researchers unparalleled access to quantitative,
kinetic cellular biology while improving data quality and streamlining image collection through automation of the cell analysis process. The IncuCyte is used at hundreds of locations across the world in labs focused on cell production, microscopy and imaging, assay development and screening. The technology is applicable to almost every cell-based research area including oncology, stem-cell science, and neurobiology. Essen serves the leading biopharmaceutical, academic and research institutions around the globe through offices in Michigan, the United Kingdom and Japan.
More at www.essenbioscience.com.